1. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023) Authors: Pignata, Sandro; Scambia, Giovanni; Schettino, Clorinda; Arenare, Laura; Pisano, Carmela; Lombardi, Davide; De Giorgi, Ugo; Andreetta, Claudia; Cinieri, Saverio; De Angelis, Carmine; Priolo, Domenico; Casanova, Claudia; Rosati, Marta; Greco, Filippo; Zafarana, Elena; Schiavetto, Ilaria; Mammoliti... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗